Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,476 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of low PAI-1 activity as a risk factor for hemorrhagic diathesis.
Agren A, Wiman B, Stiller V, Lindmarker P, Sten-Linder M, Carlsson A, Holmström M, Odeberg J, Schulman S. Agren A, et al. Among authors: carlsson a. J Thromb Haemost. 2006 Jan;4(1):201-8. doi: 10.1111/j.1538-7836.2005.01709.x. J Thromb Haemost. 2006. PMID: 16409470 Free article.
Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months.
Schulman S, Lindmarker P, Holmström M, Lärfars G, Carlsson A, Nicol P, Svensson E, Ljungberg B, Viering S, Nordlander S, Leijd B, Jahed K, Hjorth M, Linder O, Beckman M. Schulman S, et al. Among authors: carlsson a. J Thromb Haemost. 2006 Apr;4(4):734-42. doi: 10.1111/j.1538-7836.2006.01795.x. J Thromb Haemost. 2006. PMID: 16634738 Free article. Clinical Trial.
The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.
Schulman S, Granqvist S, Holmström M, Carlsson A, Lindmarker P, Nicol P, Eklund SG, Nordlander S, Lärfars G, Leijd B, Linder O, Loogna E. Schulman S, et al. Among authors: carlsson a. N Engl J Med. 1997 Feb 6;336(6):393-8. doi: 10.1056/NEJM199702063360601. N Engl J Med. 1997. PMID: 9010144 Free article. Clinical Trial.
When is it safe to stop for safety?
Schulman S, Carlsson A, Laporte S. Schulman S, et al. Among authors: carlsson a. J Thromb Haemost. 2012 Jun;10(6):1188-90. doi: 10.1111/j.1538-7836.2012.04725.x. J Thromb Haemost. 2012. PMID: 22486929 Free article. No abstract available.
A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group.
Schulman S, Rhedin AS, Lindmarker P, Carlsson A, Lärfars G, Nicol P, Loogna E, Svensson E, Ljungberg B, Walter H. Schulman S, et al. Among authors: carlsson a. N Engl J Med. 1995 Jun 22;332(25):1661-5. doi: 10.1056/NEJM199506223322501. N Engl J Med. 1995. PMID: 7760866 Free article. Clinical Trial.
Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: an open label prospective study.
Ngasala BE, Malmberg M, Carlsson AM, Ferreira PE, Petzold MG, Blessborn D, Bergqvist Y, Gil JP, Premji Z, Mårtensson A. Ngasala BE, et al. Among authors: carlsson am. Malar J. 2011 Mar 16;10:64. doi: 10.1186/1475-2875-10-64. Malar J. 2011. PMID: 21410954 Free PMC article. Clinical Trial.
Efficacy and effectiveness of artemether-lumefantrine after initial and repeated treatment in children <5 years of age with acute uncomplicated Plasmodium falciparum malaria in rural Tanzania: a randomized trial.
Ngasala BE, Malmberg M, Carlsson AM, Ferreira PE, Petzold MG, Blessborn D, Bergqvist Y, Gil JP, Premji Z, Björkman A, Mårtensson A. Ngasala BE, et al. Among authors: carlsson am. Clin Infect Dis. 2011 Apr 1;52(7):873-82. doi: 10.1093/cid/cir066. Clin Infect Dis. 2011. PMID: 21427394 Clinical Trial.
1,476 results